Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview of Alexandre Fraichard, CEO of Genoway
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Alexandre Fraichard (genOway)
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Kingwest Resources Limited Overview and 2021 Strategy Presentation at One-to-One APEC Conference
00:10:00
A CEO's Perspective on Market Dynamics and Growth Strategies in Mining and Renewable Energy Sectors | Brian Dalton, CEO, Altius Minerals Corporation.
00:10:00
Englobe Transforms Project Management with OnePlan for Enhanced Efficiency and Sustainability
00:00:00
Japara Healthcare (JHC): Andrew Sudholz, Chief Executive Officer & Executive Director
00:10:00
Salt Lake Potash: Advancing Potash Projects at One-to-One Mining Conference in London
00:10:00
Perion Network (PERI) announces the agreement with Microsoft (MSFT) Bing is no longer considered significant, as discussed by George Tsilis.
00:10:00
"EB5 Investors Project Update: Mark Davies and Peter Calabrese Discuss the CanAm Spiral Project and Investor Developments"
00:10:00
Adapting to New Business Realities in South Africa: Challenges and Resilience Amid Logistics and Energy Constraints|DR NOMBASA TSENGWA,CHIEF EXECUTIVE OFFICER,Exxaro Resources Ltd.
00:10:00
Insights from Gordon Bajnai: Chairman of Campbell Lutyens' Global Advisory Board on Private Equity and Investment Trends at IPEM 2019
00:10:00
Jerry Kalogiratos: Regional Energy Partnerships | Gerasimos (Jerry) Kalogiratos - Director and CEO of Capital Product Partners L.P.
00:10:00
Leading Plancorp Through Growth and Succession | Jeff Buckner, Chairman, Plancorp
00:10:00
Silvercorp's Recommended Offer for OreCorp vs Perseus' Hostile Bid